• Facebook
  • Instagram
  • Youtube
  • Linkedin
  • Twitter
  • Registry
  • ERBP
  • Working Groups
    • CKD-MBD
    • DESCARTES
    • DIABESITY
    • ERN
    • EUDIAL
    • EURECA-m
    • IWG
    • WGIKD
  • Committees
    • SAB
    • YNP
    • ECC
    • GNC
    • NPPC
    • Ethics Committee
    • Registry
    • ERBP
ERA-EDTA
  • ABOUT ERA-EDTA
      • WHO WE ARE
      • History
      • ERA-EDTA Facts and Dates
      • Pioneers of the European Nephrology
        • Interviews with the Masters of Nephrology
      • Obituaries
      • Mission
      • ORGANIZATION & GOVERNANCE
      • Council
        • Council Members
        • Current and Past Presidents, Officers, Editors, Council Members and Congress Presidents
        • Committees, Roles and Terms
        • Candidatures Boards and Calls
      • ORGANIZATION & GOVERNANCE
      • Group & Staff
        • ERA-EDTA
          • ERA-EDTA Operative Headquarters
        • ERA-Eurocongress Ltd
      • Constitution
      • Code of Conduct
      • Disclosure of Interest (DoI)
      • Annual Reports
      • Accounts
      • ERA-EDTA Membership
      • Benefits
      • Fees
      • Renewal
      • Members: Senior – Junior
      • Honorary Members
      • AWARDS
      • Awards 2020
      • Awards 2019
      • Awards 2018
      • ERA-EDTA Distinguished Fellow (FERA)
  • CONGRESS & MEETINGS
    • Berlin 2021
    • Paris 2022
    • Milan 2023
    • Past Congresses
    • Scientific and Educational Interaction Day (SEID)
    • CTDay
    • CEPD
    • ERA-EDTA CME Courses
  • VIRTUAL MEETING
  • SCIENCE
    • Long Term Fellowships
    • Research Programme
    • Registry Fellowships
    • Registry
    • ERACODA
  • EDUCATION
    • NEP-Nephrology Education Portal
    • Virtual Meeting
    • e-seminars
    • GlomCon Webinars
    • Short Term Clinical Fellowships
    • ERA-EDTA CME Courses
    • Patient Information
      • Initiatives for patients
      • Patient Associations
    • ERA-EDTA Endorsement/Non-Financial Support
    • European Specialty Examination in Nephrology (ESENeph)
    • COVID-19 News and Information
  • NETWORKING
  • GUIDELINES
  • JOURNALS & PRESS
      • NDT
      • CKJ
      • Cardio-renal research
      • EDTA Proceedings
      • Newsletter & Press Releases
        • Nephrology News Flash
        • NEP Newsletter
        • Press Releases
      • News
      • EDTA Proceedings
      • Press and Social Media Policies
  • PUBLIC AFFAIRS
    • Collaboration with Societies
    • National Societies
      • National Societies of Nephrology List
    • ASN ERA-EDTA ISN Collaboration
    • EKHA
    • Biomedical Alliance in Europe
    • ERA-EDTA Endorsement/Non-Financial Support
    • Link Exchange
  • Search
  • Menu
  • My ERA-EDTA
  • Contact us
  • MEMBERSHIP
  • MEMBERSHIP
  • My Era-Edta
  • Contact us
  • ABOUT ERA-EDTA
    • Who we are
      • History
      • ERA-EDTA Facts and Dates
      • Mission
    • Organization & Governance
      • Council
        • Council Members
        • Current and Past Presidents, Officers, Editors, Council Members and Congress Presidents
        • Committees, Roles and Terms
    • Group & Staff
      • ERA-EDTA
      • ERA-EDTA Operative Headquarters
      • ERA-Eurocongress Ltd
      • Constitution
      • Code of Conduct
      • Annual Reports
      • Accounts
    • ERA-EDTA Membership
      • Benefits
      • Membership Fees
      • Renewal
      • Members: Senior – Junior
    • AWARDS
      • Awards 2020
      • Awards 2019
      • Awards 2018
      • ERA-EDTA Distinguished Fellow (FERA)
  • CONGRESS & MEETINGS
    • Berlin 2021
    • Paris 2022
    • Milan 2023
    • Scientific and Educational Interaction Day (SEID)
    • CTDay
    • CEPD
    • ERA-EDTA CME Courses
  • VIRTUAL MEETING
  • SCIENCE
    • Long Term Fellowships
    • Research Programme
    • Registry Fellowships
    • Registry
    • ERACODA
  • EDUCATION
    • NEP-Nephrology Education Portal
    • Virtual Meeting
    • e-seminars
    • GlomCon Webinars
    • Short Term Clinical Fellowships
    • ERA-EDTA CME Courses
    • Initiatives for patients
    • Patient Associations
    • ERA-EDTA Endorsement/Non-Financial Support
    • European Specialty Examination in Nephrology (ESENeph)
    • COVID-19 News and Information
  • NETWORKING
  • GUIDELINES
  • JOURNALS & PRESS
    • NDT
    • CKJ
    • Cardio Renal Research
    • Newsletter & Press Releases
      • Nephrology News Flash
      • NEP-Nephrology Education Portal Newsletters
      • Press Releases
    • News
    • EDTA PROCEEDINGS
    • Press and Social Media Policies
  • PUBLIC AFFAIRS
    • Collaboration with Societies
    • National Societies
    • ASN ERA-EDTA ISN Collaboration
    • EKHA
    • ERA-EDTA Endorsement/Non-Financial Support
    • Link Exchange
  • Registry
  • ERBP
  • Working Groups
    • CKD-MBD
    • DESCARTES
    • DIABESITY
    • ERN
    • EUDIAL
    • EURECA-m
    • IWG
    • WGIKD
  • Committees
    • SAB
    • YNP
    • ECC
    • GNC
    • NPPC
    • Ethics Committee
    • Registry
    • ERBP

Valsartan combined with vitamin D more efficiently reduces moderate proteinuria in IgA nephropathy

News, News-Home

IgA nephropathy is a leading causes of chronic renal disease and end stage renal disease (ESRD). The risk of progression to ESRD is associated with the level of proteinuria, thus underlining the importance of adequate proteinuria control. A prospective, single-center, randomized controlled study followed patients with IgA nephropathy and moderate proteinuria of 1.0–3.0 g/24 h receiving valsartan, either alone or combined with calcitriol. While both groups achieved a significant decrease in proteinuria, the change was more prominent in the combination group. The incidence of adverse effects was similar, and no significant change in blood pressure, estimated glomerular filtration rate, serum calcium or serum potassium was observed.

Read the article

24 January 2020/by ERA-EDTA
Tags: ESRD, IgA nephropathy, IGaN, Vitamin D
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on Pinterest
  • Share on Linkedin
  • Share on Reddit
  • Share by Mail
  • Share on WhatsApp
https://www.era-edta.org/en/wp-content/uploads/2020/01/vitamin_d.jpg 1824 2736 ERA-EDTA ERA-EDTA2020-01-24 08:17:222020-01-24 08:17:22Valsartan combined with vitamin D more efficiently reduces moderate proteinuria in IgA nephropathy
You might also like
Effects of Vitamin D supplementation on vascular calcification progression in CKD patients with hypovitaminosis D
Machine learning model for risk stratification in IgA Nephropathy
  • The risks of gastrointestinal adverse events with initiation of sodium polystyrene sulphonate19 October 2020 - 10:55
  • Are all donated kidneys the same?16 October 2020 - 11:40
  • Which phosphate transporters should be targeted to reduce hyperphosphatemia?14 October 2020 - 10:02
  • Does ADH modulate renal calcium excretion in patients with CDI and hypercalciuria?12 October 2020 - 16:31

ERA-EDTA Operative Headquarters
Strada dei Mercati 16/A
I-43126 Parma – Italy
Phone: +39 0521 989078
E-mail: secretariat@era-edta.org

ERA-EDTA Registered Office
c/o PKF Littlejohn, 15 Westferry Circus, Canary Wharf
London E14 4HD – United Kingdom

You are here: Home / Valsartan combined with vitamin D more efficiently reduces moderate proteinuria...

  • ABOUT ERA-EDTA
  • CONGRESS & MEETINGS
  • JOURNAL & PRESS
  • EDUCATION
  • PUBLIC AFFAIRS
  • GUIDELINES

  • My ERA-EDTA
  • Contact us
  • MEMBERSHIP
.av-share-box ul li{ display: none!important; }

  • Share on Facebook
  • Share on Twitter
  • Share on Pinterest
  • Share on Linkedin
  • Share on Reddit
  • Share by Mail
  • Share on WhatsApp
© Copyright - Era-Edta
  • Terms and Conditions
  • Cookie Policy
  • Privacy Policy
  • Facebook
  • Instagram
  • Youtube
  • Linkedin
  • Twitter
Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

OKLearn more